Skip to content
BidBenchmark
SolicitationAmendment 2

Quetiapine Fumarate XR Tablets

DLA TROOP SUPPORT

View authoritative SAM noticeSign in to watch

Response status

Historical record

May 19, 2023, 7:00 PM UTC

This notice is no longer open.

Posted
May 2, 2023
Archive date
May 19, 2029
SAM status
Active
This is a preserved solicitation record. The response window is closed because the published deadline passed.

Answer-first brief

What the source record says

  • DLA TROOP SUPPORT published this solicitation.
  • The notice uses NAICS 325412 (Pharmaceutical Preparation Manufacturing).

Procurement identity

Notice ID
5638f6e61f4442d28dd36c7811458ddd
Solicitation
SPE2D223R0010
Base type
Solicitation
Version
2 of 2

Solicitation facts

Structured fields from the current SAM notice version. A dash means the source did not publish a value.

Notice type
Solicitation
Solicitation number
SPE2D223R0010
NAICS
325412 — Pharmaceutical Preparation Manufacturing
PSC
6505 — DRUGS AND BIOLOGICALS
Set-aside
—
Set-aside code
—
Posted
May 2, 2023
Responses due
May 19, 2023, 7:00 PM UTC
Archive date
May 19, 2029
Archive type
autocustom
Base type
Solicitation
Organization type
OFFICE
Benchmark category
—
Category confidence
—
Category source
—
Last seen
Aug 29, 2026

Buyer and place

Office hierarchy and place of performance as published.

Department
DEPT OF DEFENSE
Department code
—
Subagency
Defense Logistics Agency
Subagency code
—
Office
DLA TROOP SUPPORT
Organization path
—
Organization path codes
—
Office address
PHILADELPHIA, PA, 19111, USA
Place of performance
—
City code
—
State
—
State code
—
Postal code
—
Country
—

Points of contact

Contact details from the current notice version.

Notice description

Source text reproduced without an AI summary.

Amendment 0003 SPE2D2-23-R-0010 issued May 2, 2023 to extend the closing date from May 5, 2023 3:00 PM EDT to May 19, 2023 3:00 PM EDT. Amendment 0002 SPE2D2-23-R-0010 issued April 18, 2023 to extend the closing date from April 21, 2023 3:00 PM EDT to May 5, 2023 3:00 PM EDT. Amendment 0001 SPE2D2-23-R-0010 issued April 12, 2023 to change the size standard for NAICS code from 1250 to 1300 on page 1, block 10 of the Standard Form 1449. Quetiapine Fumarate XR - SPE2D2-23-R-0010 - Solicitation

Comparable award range

Historical award values for work matched by the fixed rubric—not an estimate of this opportunity.

No past awards scored highly enough to form a comparable range.

Comparable awards

The match score is decomposed so each comparison can be challenged.

No comparable awards are attached to this notice.

Amendment history

A version is preserved whenever the normalized notice contents change.

VersionNotice typeObservedResponses dueContent hash
1SolicitationAug 10, 2026May 19, 2023, 7:00 PM UTCcebdf82a5ed3d636
2SolicitationAug 28, 2026May 19, 2023, 7:00 PM UTC4c7643b220a6c678

Record provenance

Field-level lineage for the current opportunity version.

FieldSourceSource as ofParserTransform
agency_nameSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
archive_dateSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
archive_typeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
base_typeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
contactsSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
descriptionSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
naics_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
notice_idSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
notice_typeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_citySAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_country_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_nameSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_postal_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_state_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
organization_typeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
posted_dateSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
psc_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
response_deadlineSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
sam_urlSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
solicitation_numberSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
subagency_nameSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
titleSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
upstream_activeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

  1. 1Notice fields come from the SAM.gov contract opportunities record last seen Aug 29, 2026. SAM.gov remains authoritative.

Note 1 covers the solicitation record. No synthetic FAQ or inferred solicitation value is published.

Quetiapine Fumarate XR Tablets — federal contract opportunity · BidBenchmark